{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:48:23Z","timestamp":1789670903740,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020956","name":"Merck Healthcare KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.msard.2025.106899","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:14:42Z","timestamp":1765037682000},"page":"106899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Usage and limitations of neuroglial biomarkers NfL and GFAP in urine as non-invasive disease markers in multiple sclerosis"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1088-9558","authenticated-orcid":false,"given":"Konstantin","family":"Kohlhase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helai","family":"Nassir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Grefkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavor","family":"Yalachkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinand O.","family":"Bohmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Maiworm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Siebenbrodt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Heuser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"G\u00f6pfert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Luger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Foerch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2025.106899_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-33158-8","article-title":"Serum GFAP as a biomarker for disease severity in multiple sclerosis","volume":"8","author":"Abdelhak","year":"2018","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.msard.2025.106899_bib0011","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/acn3.51969","article-title":"Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis","volume":"11","author":"Abdelhak","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"8","key":"10.1016\/j.msard.2025.106899_bib0009","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1093\/brain\/awy154","article-title":"Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis","volume":"141","author":"Barro","year":"2018","journal-title":"Brain : J. Neurol."},{"issue":"8","key":"10.1016\/j.msard.2025.106899_bib0033","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1038\/s41380-024-02524-6","article-title":"Introducing neurofilament light chain measure in psychiatry: current evidence, opportunities, and pitfalls","volume":"29","author":"Bavato","year":"2024","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.msard.2025.106899_bib0008","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","article-title":"Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study","volume":"21","author":"Benkert","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2025.106899_bib0013","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.msard.2025.106899_bib0018","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/path.1650","article-title":"The cytoskeleton in neurodegenerative diseases","volume":"204","author":"Cairns","year":"2004","journal-title":"J. Pathol."},{"issue":"7","key":"10.1016\/j.msard.2025.106899_bib0021","first-page":"e733","article-title":"Prognostic value of serum neurofilaments in patients with clinically isolated syndromes","volume":"92","author":"Costa","year":"2019","journal-title":"Neurology."},{"issue":"8","key":"10.1016\/j.msard.2025.106899_bib0019","doi-asserted-by":"crossref","first-page":"393","DOI":"10.6026\/97320630011393","article-title":"Modelling and characterization of glial fibrillary acidic protein","volume":"11","author":"Deka","year":"2015","journal-title":"Bioinformation."},{"issue":"6","key":"10.1016\/j.msard.2025.106899_bib0004","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.24954","article-title":"Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis","volume":"81","author":"Disanto","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2025.106899_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.104970","article-title":"Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management","volume":"101","author":"Freedman","year":"2024","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.msard.2025.106899_bib0017","doi-asserted-by":"crossref","first-page":"e5146","DOI":"10.1371\/journal.pone.0005146","article-title":"An attempt to understand Kidney\u2019s protein handling function by comparing plasma and urine proteomes","volume":"4","author":"Jia","year":"2009","journal-title":"PLoS. One"},{"issue":"2","key":"10.1016\/j.msard.2025.106899_bib0028","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3390\/ijms26020748","article-title":"Exploring the link between renal function fluctuations within the physiological range and serum\/CSF levels of NfL, GFAP, tTAU, and UCHL1","volume":"26","author":"Koerbel","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.msard.2025.106899_bib0020","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/ene.15641","article-title":"Brain-specific biomarkers in urine as a non-invasive approach to monitor neuronal and glial damage","volume":"30","author":"Kohlhase","year":"2023","journal-title":"Eur. J. Neurol."},{"issue":"8","key":"10.1016\/j.msard.2025.106899_bib0034","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00415-025-13246-2","article-title":"Longitudinal evaluation of serum neurofilament light levels in normal healthy volunteers: defining a threshold of concern","volume":"272","author":"Lanz","year":"2025","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2025.106899_bib0015","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.V1341034","article-title":"Use of the albumin\/creatinine ratio to detect microalbuminuria: implications of sex and race","volume":"13","author":"Mattix","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.msard.2025.106899_bib0005","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1515\/revneuro-2020-0145","article-title":"Neuronal and glial CSF biomarkers in multiple sclerosis: a systematic review and meta-analysis","volume":"32","author":"Momtazmanesh","year":"2021","journal-title":"Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.msard.2025.106899_bib0007","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1352458517751049","article-title":"ECTRIMS\/EAN guideline on the pharmacological treatment of people with multiple sclerosis","volume":"24","author":"Montalban","year":"2018","journal-title":"Mult. Scler."},{"issue":"9","key":"10.1016\/j.msard.2025.106899_bib0010","first-page":"17","article-title":"Neurofilament light chain in blood as a diagnostic and predictive biomarker for multiple sclerosis: a systematic review and meta-analysis","author":"Ning","year":"2022","journal-title":"PLoS. One"},{"key":"10.1016\/j.msard.2025.106899_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105815","article-title":"Comparison of SIMOA and VEUS technologies for serum neurofilament light chain measurement in multiple sclerosis","volume":"90","author":"Pelisek","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106899_bib0030","unstructured":"Quanterix - GFAP. Simoa GFAP Advantage PLUS Kit HD-X data sheet. Retrieved August 10, 2025, from https:\/\/www.quanterix.com\/wp-content\/uploads\/2024\/04\/GFAP-Advantage-PLUS-Data-Sheet.pdf."},{"key":"10.1016\/j.msard.2025.106899_bib0031","unstructured":"Quanterix - NFL. Simoa NF-LIght advantage PLUS Kit HD-X data sheet. Retrieved August 10, 2025, from https:\/\/www.quanterix.com\/wp-content\/uploads\/2024\/01\/NF-Light-Advantage-PLUS-Data-Sheet-HD-X.pdf."},{"key":"10.1016\/j.msard.2025.106899_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102810","article-title":"Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis","volume":"50","author":"Saraste","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2025.106899_bib0016","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1755-8794-1-41","article-title":"A high confidence, manually validated human blood plasma protein reference set","volume":"1","author":"Schenk","year":"2008","journal-title":"BMC Med Genom."},{"issue":"5","key":"10.1016\/j.msard.2025.106899_bib0027","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/archinte.1987.00370050135022","article-title":"Quantitation of proteinuria by the use of protein-to-creatinine ratios in random urine samples","volume":"147","author":"Schwab","year":"1987","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"10.1016\/j.msard.2025.106899_bib0022","doi-asserted-by":"crossref","first-page":"fcac174","DOI":"10.1093\/braincomms\/fcac174","article-title":"Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5-90 years","volume":"4","author":"Simr\u00e9n","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.msard.2025.106899_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103535","article-title":"High or increasing serum NfL is predictive of impending multiple sclerosis relapses","volume":"59","author":"Thebault","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106899_bib0029","doi-asserted-by":"crossref","unstructured":"Thomas, C.E., Sexton, W., Benson, K., Sutphen, R., & Koomen, J. (2010). Urine collection and processing for protein biomarker discovery and quantification. Cancer Epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 19(4), 953\u2013959. https:\/\/doi.org\/10.1158\/1055-9965.EPI-10-0069.","DOI":"10.1158\/1055-9965.EPI-10-0069"},{"issue":"2","key":"10.1016\/j.msard.2025.106899_bib0014","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2025.106899_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2019.00338","article-title":"Neurofilament light chain as a biomarker in multiple sclerosis","volume":"10","author":"Varhaug","year":"2019","journal-title":"Front. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2025.106899_bib0026","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ki.2010.165","article-title":"Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate","volume":"78","author":"Waikar","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.msard.2025.106899_bib0001","doi-asserted-by":"crossref","unstructured":"Walton, C., King, R., Rechtman, L., Kaye, W., Leray, E., Marrie, R.A., Robertson, N., La Rocca, N., Uitdehaag, B., van der Mei, I., Wallin, M., Helme, A., Angood Napier, C., Rijke, N., & Baneke, P. (2020). Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult. Scler., 26(14), 1816\u20131821. https:\/\/doi.org\/10.1177\/1352458520970841.","DOI":"10.1177\/1352458520970841"},{"issue":"4","key":"10.1016\/j.msard.2025.106899_bib0012","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/2211068215589580","article-title":"The Simoa HD-1 analyzer: a novel fully automated digital immunoassay analyzer with single-molecule sensitivity and multiplexing","volume":"21","author":"Wilson","year":"2016","journal-title":"J. Lab. Autom."},{"issue":"1","key":"10.1016\/j.msard.2025.106899_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-019-1674-2","article-title":"Molecular biomarkers in multiple sclerosis","volume":"16","author":"Ziemssen","year":"2019","journal-title":"J. Neuroinflammation."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825006376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825006376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:49:37Z","timestamp":1781509777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825006376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":34,"alternative-id":["S2211034825006376"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106899","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usage and limitations of neuroglial biomarkers NfL and GFAP in urine as non-invasive disease markers in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106899","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106899"}}